Can a gene therapy reverse aging in the eye? new trial begins
Disease control
Recruiting now
This early-stage trial is testing a single dose of ER-100, a gene therapy designed to reverse age-related changes in retinal cells, in 18 adults with open-angle glaucoma or NAION. Participants receive the therapy via an eye injection and take doxycycline for 8 weeks to activate i…
Phase: PHASE1 • Sponsor: Life Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC